Clinical Diagnostics in China: Market Analysis and Participant Directory

Questions: Discounts, Updates etc.

Pages: 260

Price (Single): $18,000.00

Price (Company): $36,000.00

Publication Date: 2008-01-15

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

This country of 1.3 billion people is now America’s sixth largest export market, and China’s economy, which has been growing at an average rate of 8% over the last 20 years, grew over 9% last year.

 

Combined with this impressive overall growth, a number of recent events and trends in the Chinese healthcare environment are making China an increasingly attractive market opportunity for in vitro diagnostics companies. China’s accession to the World Trade Organization (WTO) has made doing business in China much easier for diagnostic companies by reducing tariffs and opening the door for foreign firms to control their own distribution. The increasing numbers of private laboratories and expanded reference laboratories are expanding the market for tests of all kinds.

 

Although there are a number of challenges for diagnostic manufacturers to understand and overcome, the market for clinical diagnostics in China (both reagents and instruments) remains one of the most promising emerging markets in the world.

 

The report covers seven market segments:

For each segment, the report provides key market data such as market size, number of labs and their workload, level of automation, and market share for both instrument and reagent competitors, foreign and domestic.

Perhaps the most valuable part of the report, however, is the extensive listing of market participants. The report profiles:

This report, produced jointly with the firm McEvoy & Farmer, is the product of years of on-the-ground research in China. Although the focus is on what is happening now, the report provides historical background from McEvoy & Farmer’s 12+ years of studying IVD markets in Asia and particularly China. This report contains profiles of the following companies active in IVD in China:

Table of Contents


Preface: A Note on Terminology
Chapter One: Country SummaryThe Economic Climate and HealthcareSystem in China

 

Chapter Two: Market Sector Analyses

Chapter Three: International&Domestic Manufacturer Profiles

Appendix: Distributor Cross-Reference

Other users found this report page using the following search terms: china diagnostics china market diagnostics clinical diagnostic medical analysis ivd companies analyzer

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.